MARKET

SER

SER

Serina Therapeutics
AMEX
1.700
-0.130
-7.10%
Opening 12:08 02/17 EST
OPEN
1.890
PREV CLOSE
1.830
HIGH
1.950
LOW
1.680
VOLUME
129.54K
TURNOVER
--
52 WEEK HIGH
7.92
52 WEEK LOW
1.651
MARKET CAP
18.13M
P/E (TTM)
-0.9034
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SER last week (0209-0213)?
Weekly Report · 1d ago
Weekly Report: what happened at SER last week (0202-0206)?
Weekly Report · 02/09 09:31
Insider Shake-Up Sends Serina Therapeutics Buzzing
TipRanks · 02/04 02:04
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event
Barchart · 02/03 05:00
Xpeng, Serina Therapeutics, Dragonfly Energy Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga · 02/02 13:07
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 02/02 12:05
Why DarkIris Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket
Benzinga · 02/02 10:17
Weekly Report: what happened at SER last week (0126-0130)?
Weekly Report · 02/02 09:30
More
About SER
Serina Therapeutics Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. The Company's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.

Webull offers Serina Therapeutics Inc stock information, including AMEX: SER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SER stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SER stock methods without spending real money on the virtual paper trading platform.